Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract - HSV - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2017-06-02 05:25:57		Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664 Add to Reading List Source URL: www.takara-bio.co.jp Download Document from Source Website File Size: 478,76 KB Share Document on Facebook